Breaking News Instant updates and real-time market news.

GE

General Electric

$16.26

-0.51 (-3.04%)

06:35
01/22/18
01/22
06:35
01/22/18
06:35

General Electric downgraded to Neutral from Buy at BofA/Merrill

  • 24

    Jan

GE General Electric
$16.26

-0.51 (-3.04%)

01/08/18
JPMS
01/08/18
NO CHANGE
Target $16
JPMS
Underweight
JPMorgan sees 'too many risks,' cuts GE price target to $16
JPMorgan analyst C. Stephen Tusa says he sees "too many risks" to change his view on shares of General Electric. The analyst keeps an Underweight rating on the name and cut his price target for the stock to $16 from $17. There is no other company in the sector where earnings and free cash expectations were cut by 50% last year, Tusa tells investors in a research note. GE's leverage remains high and one-third of its core business lacks a "credible turnaround plan in the face of a dramatic fundamental shift," Tusa writes.
01/12/18
JPMS
01/12/18
NO CHANGE
JPMS
Underweight
GE management changes 'red flags for ongoing concern,' says JPMorgan
The recently announced departures of key executives at General Electric, namely Joe Mastrangelo, CEO of Gas Power Systems this week, and Rich Laxer CEO of GE Capital in late December, should not be overlooked, JPMorgan analyst C. Stephen Tusa tells investors in a research note. The departures are "further red flags around the uncertainties that remain" and for the company's "ongoing concern," Tusa contends. The analyst continues to think that calls for a bottom based "merely on stock price continue to ignore the fundamental realities at play" relating to GE's leverage, "weak" free cash flow, and "challenged" businesses like Power. Tusa thinks "there are still shoes to drop." He keeps an Underweight rating on General Electric.
01/16/18
STFL
01/16/18
NO CHANGE
Target $18
STFL
Hold
Stifel says GE update on insurance review 'unsurprising,' but also 'ungood'
After General Electric announced that the comprehensive review and reserve testing for GE Capital's run-off insurance portfolio will result in a $6.2B after-tax GAAP charge in Q4 and that GE Capital will fund the contributions and suspend its dividend to GE for the foreseeable future, Stifel analyst Robert McCarthy called the update "largely telegraphed and unsurprising, but ungood." McCarthy keeps a Hold rating and $18 price target on GE shares ahead of the company's conference call to discuss the matter further.
01/19/18
DBAB
01/19/18
NO CHANGE
Target $15
DBAB
Sell
GE may be forced to raise equity capital, says Deutsche Bank
Given General Electric's current "cash squeeze" and growing liquidity pressures, the company may ultimately be forced to raise equity capital, Deutsche Bank analyst John Inch tells investors in a research note. With the company screening as overvalued, it may be in its "best interest to raise equity capital sooner while its stock is still elevated," Inch adds. The analyst lists the capital funding gap to pay its $15B insurance reserve bill, the potential for additional mandated insurance reserve contributions and "rapidly" rising debt as GE's remaining challenges. He also believes the dividend could be cut further. Inch keeps a Sell rating on General Electric with a $15 price target.

TODAY'S FREE FLY STORIES

11:25
11/21/18
11/21
11:25
11/21/18
11:25
General news
Treasury's 10-year TIPS preview: the $11 B reopening may be weakened »

Treasury's 10-year…

AMD

AMD

$19.24

0.04 (0.21%)

11:20
11/21/18
11/21
11:20
11/21/18
11:20
Options
Sweep buyers of AMD weekly puts »

Sweep buyers of AMD…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 06

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
11/21/18
11/21
11:17
11/21/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
11/21/18
11/21
11:16
11/21/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYAD

Celyad

$26.97

(0.00%)

, BLUE

Bluebird Bio

$116.82

0.55 (0.47%)

11:11
11/21/18
11/21
11:11
11/21/18
11:11
Conference/Events
William Blair biotech analysts to hold an analyst/industry conference call »

Biotech Analysts, along…

CYAD

Celyad

$26.97

(0.00%)

BLUE

Bluebird Bio

$116.82

0.55 (0.47%)

NVS

Novartis

$88.49

1.51 (1.74%)

GILD

Gilead

$67.04

-0.54 (-0.80%)

CELG

Celgene

$67.69

0.93 (1.39%)

AUTL

Autolus Therapeutics

$42.60

1.4 (3.40%)

ALLO

Allogene Therapeutics

$26.40

0.79 (3.08%)

CLLS

Cellectis

$20.89

0.65 (3.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

  • 27

    Nov

  • 27

    Nov

  • 29

    Nov

  • 01

    Dec

  • 02

    Dec

  • 02

    Dec

  • 03

    Dec

  • 03

    Dec

  • 03

    Dec

  • 10

    Dec

  • 13

    Dec

11:10
11/21/18
11/21
11:10
11/21/18
11:10
General news
2-Yr FRN Note Announcement CUSIP Number data reported »

2-Yr FRN Note…

11:10
11/21/18
11/21
11:10
11/21/18
11:10
General news
2-Yr FRN Note Announcement Offering Amount data reported »

2-Yr FRN Note…

11:10
11/21/18
11/21
11:10
11/21/18
11:10
General news
7-Yr Note Announcement CUSIP Number data reported »

7-Yr Note Announcement…

11:10
11/21/18
11/21
11:10
11/21/18
11:10
General news
7-Yr Note Announcement Offering Amount data reported »

7-Yr Note Announcement…

11:10
11/21/18
11/21
11:10
11/21/18
11:10
General news
5-Yr Note Announcement CUSIP Number data reported »

5-Yr Note Announcement…

11:10
11/21/18
11/21
11:10
11/21/18
11:10
General news
5-Yr Note Announcement Offering Amount data reported »

5-Yr Note Announcement…

11:10
11/21/18
11/21
11:10
11/21/18
11:10
General news
2-Yr Note Announcement CUSIP Number data reported »

2-Yr Note Announcement…

11:10
11/21/18
11/21
11:10
11/21/18
11:10
General news
2-Yr Note Announcement Offering Amount data reported »

2-Yr Note Announcement…

11:10
11/21/18
11/21
11:10
11/21/18
11:10
General news
3-Month Bill Announcement Offering Amount data reported »

3-Month Bill Announcement…

11:10
11/21/18
11/21
11:10
11/21/18
11:10
General news
6-Month Bill Announcement Offering Amount data reported »

6-Month Bill Announcement…

QQQ

Invesco QQQ Trust

$161.12

1.93 (1.21%)

11:10
11/21/18
11/21
11:10
11/21/18
11:10
Options
Notable put ratio spread opened in Invesco QQQ options as shares bounce »

Notable put ratio spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YORW

York Water

$32.80

(0.00%)

11:08
11/21/18
11/21
11:08
11/21/18
11:08
Hot Stocks
York Water raises dividend 4% to 17.33c per share »

York Water announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXAS

Exact Sciences

$65.20

0.43 (0.66%)

11:07
11/21/18
11/21
11:07
11/21/18
11:07
Periodicals
Analyst thinks Jana could pressure Exact Sciences to pursue sale, The Deal says »

Activist investor Jana…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 30

    Nov

11:05
11/21/18
11/21
11:05
11/21/18
11:05
General news
Euro$ interest rate futures were checked lower »

Euro$ interest rate…

11:05
11/21/18
11/21
11:05
11/21/18
11:05
General news
FX Action: USD-CAD »

FX Action: USD-CAD ticked…

DE

Deere

$143.73

5.24 (3.78%)

11:00
11/21/18
11/21
11:00
11/21/18
11:00
Hot Stocks
Breaking Hot Stocks news story on Deere »

Deere says November…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

ALT

Altimmune

$3.21

0.2 (6.64%)

10:58
11/21/18
11/21
10:58
11/21/18
10:58
Hot Stocks
Altimmune granted European patent for influenza antigen delivery vectors »

A post to the European…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NYMX

Nymox

$1.81

0.07 (4.02%)

10:58
11/21/18
11/21
10:58
11/21/18
10:58
Hot Stocks
Nymox director James George Robinson buys 9K shares of company stock »

Nymox director James…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QEP

QEP Resources

$8.81

-0.3 (-3.29%)

10:55
11/21/18
11/21
10:55
11/21/18
10:55
Options
QEP Resources put volume heavy and directionally bearish »

Bearish flow noted in QEP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLW

Corning

$31.21

0.37 (1.20%)

, T

AT&T

$29.82

0.41 (1.39%)

10:55
11/21/18
11/21
10:55
11/21/18
10:55
Conference/Events
UBS optical/networking equip analyst to hold analyst/industry conference call »

Optical & Networking…

GLW

Corning

$31.21

0.37 (1.20%)

T

AT&T

$29.82

0.41 (1.39%)

VZ

Verizon

$59.30

-0.16 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 26

    Nov

  • 03

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.